Elevated proinsulin levels related to islet cell antibodies in first-degree relatives of IDDM patients

Diabetes Care

Volumn 15, Issue 5, 1992, Pages 632-637

  Spinas, Giatgen A ^a   Snorgaard, Ole ^b   Hartling, Svend G ^b   Oberholzer, Martin ^b   Berger, Willi ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PANCREAS ISLET CELL ANTIBODY; PROINSULIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET CELL; PARENT; PRIORITY JOURNAL; RELATIVE; SIBLING;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FASTING; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HLA-DR ANTIGENS; HUMANS; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; NUCLEAR FAMILY; PROBABILITY; PROINSULIN; REFERENCE VALUES;

EID: 0026585133     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.15.5.632     Document Type: Article

References (28)

1. Scott J, Nerup J, Lernmark A: Immunologic factors in diabetes mellitus. In Clinical Immunology. Update Reviews for Physicians. Rosse WF, Ed. Amsterdam, Elsevier, 1985, p. 53-85
2. Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG: Evidence for a long prediabetic period in type 1 (insulin-dependent) diabetes mellitus. Lancet 2:1363-65, 1981
3. Johnston C, Millward BA, Hoskins P, Leslie RDG, Bottazzo GF, Pyke DA: Islet cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes: a study in identical twins. Diabetologia 32:382-86, 1989
4. Spencer KM, Tarn A, Dean BM, Lister J, Bottazzo GF: Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes. Lancet 1:284-85, 1982
5. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS: First-degree relatives of patients with type 1 diabetes mellitus: islet-cell antibodies and abnormal insulin secretion. N Engl J Med 313: 461-64, 1985
6. Riley WJ, MacLaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, Schwartz S, Malone J, Shah S, Vadheim C, Rotter JI: A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323:1167-72, 1990
7. Heaton DA, Millward BA, Gray IP, Tun Y, Hales CN, Pyke DA, Leslie RDG: Increased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 insulin-dependent diabetic patients. Diabetologia 31:182-84, 1988
8. Hartling SG, Lindgren F, Dahlqvist G, Persson B, Binder C: Elevated proinsulin in healthy siblings of IDDM patients independent of HLA identity. Diabetes 38: 1271-74, 1989
9. Heding LG, Ludvigsson J, Kasperska-Czyzykowa T: B-cell secretion in non-diabetic and insulin-dependent diabetics. Acta Med Scand 659 (Suppl.):5-9, 1981
10. Snorgaard O, Hartling SG, Binder C, Canadian/European Diabetes Study Group: Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33:36-42, 1990
11. Ward WK, LaCava EC, Paquette TL, Beard JC, Wallum BJ, Porte D Jr: Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30:698-702, 1987
12. Mako ME, Starr JI, Rubenstein AH: Circulating proinsulin in patients with maturity onset diabetes. Am J Med 63:865-69, 1977
13. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider HE, Sobey WJ, Hales CN: Insulin deficiency in non-insulin dependent diabetes. Lancet 1:293-95, 1989
14. Gordon P, Sherman BM, Simopoulos AP: Glucose intolerance with hypokalemia: an increased proportion of circulating proinsulin like component. J Clin Endocrinol Metab 34:235-40, 1972
15. Hartling SG, Garne S, Binder C, Heilmann C, Petersen W, Petersen KE, Koch C: Proinsulin, insulin and C-peptide in cystic fibrosis after an oral glucose tolerance test. Diabetes Res 7:165-69, 1988
16. Spinas GA, Keller U, Neri TM, Matter L, Staffelbach O, Berger W: HLA-Antigene und Inselzellenantikörper bei Typ-1-Diabetikern verschiedener Altersgruppen und ihren Verwandten I. Grades. Schweiz Med Wschr 115:48-54, 1985
17. Spinas GA, Matter L, Wilkin T, Staffelbach O, Berger W: Islet-cell and insulin autoantibodies in first-degree relatives of type 1 diabetics: a 5-year follow-up study in a Swiss population. In Prediabetes. Camerini-Davalos RA, Cole HS, Eds. New York, Plenum, 1988, p. 209-14
18. Hartling SG, Dinesen B, Kappelgaard AM, Faber OK, Binder C: ELISA for human proinsulin. Clin Chim Acta 156: 289-98, 1986
19. Bottazzo GF, Florin-Christensen A, Doniach D: Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 2:1279-83, 1974
20. Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D: Complement-fixing islet-cell antibodies in type-1 diabetes: possible monitors of active beta-cell damage. Lancet 1:668-72, 1980
21. Wilkin TJ, Hoskins PJ, Armitage M, Rodier M, Casey C, Diaz J, Pyke DA, Leslie RDG: Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet 1:480-82, 1985
22. McCulloch DK, Klaff LJ, Kahn SE, Schoenfeld SL, Greenbaum CJ, Manseth R, Benson EA, Nepom GT, Shewey L, Palmer JP: Nonprogression of subclinical β-cell dysfunction among first-degree relatives of IDDM patients: 5-yr follow up of the Seattle family study. Diabetes 39:549-56, 1990
23. Palmer JP, McCulloch DK: Prediction and prevention in IDDM - 1991. Diabetes 40:943-47, 1991
24. Ziegler AG, Dumont Herskowitz R, Jackson RA, Soeldner JS, Eisenbarth GS: Predieting type I diabetes. Diabetes Care 13: 762-75, 1990
25. Sobey WJ, Beer SF, Carrington CA, Clark PMS, Frank BH, Gray IP, Luzio SD, Owens DR, Schneider AE, Siddle K, Temple RC, Hales CN: Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J 260:535-41, 1989
26. Bergenstal RM, Cohen RM, Lever E, Polonsky K, Jaspan J, Blix PM, Revers R, Olefsky JM, Kolterman O, Steiner K, Cherrington A, Frank B, Galloway J, Rubenstein AH: The metabolic effects of biosynthetic human proinsulin in individuals with type 1 diabetes. J Clin Endocrinol Metab 58:973-79, 1984
27. Polonsky K, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B: Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type 1 diabetic patients. J Clin Invest 77:98-105, 1986
28. Spinas GA, Hansen BS, Linde S, Kastern W, Mandrup-Poulsen T, Molvig J, Nielsen JH, Dinarello CA, Nerup J: Interleukin 1 dose-dependently affects the biosynthesis of (pro)insulin in isolated rat islets of Langerhans. Diabetologia 30: 474-80, 1987